Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation ... positive for the HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc).
Hepatitis B e antigen usually indicates active HBV replication ... These patients usually harbor precore/core promoter mutations in the HBV genome that prevent or decrease the production of ...
Blood testing for HIV antigen and antibodies was negative; a PCR assay for HIV RNA was also negative. Blood tests for hepatitis A virus IgM, hepatitis B virus core IgM, hepatitis B virus surface ...
Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...
In addition to HBsAg, other viral markers such as hepatitis B core-related antigen (HBcrAg) are available, but their potential association with HBV-specific immune responses is not defined yet, which ...
Patients were monitored till 48 weeks with baseline and serial measurements of serum HBsAg, HBV RNA and hepatitis B core-related antigen. NUCs were resumed when HBV DNA reaches >2000 IU/mL regardless ...
Hepatitis B surface antigen (HBsAg), core total antibody (anti-HBc) and surface antibody (anti-HBs) were detected by the Architect immunoassay (Abbott Diagnostics, Germany). Hepatitis B infection was ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback